Conceptio › Archive › HAL (France)
HAL (France)open access

Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study

Benoit Godbert et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
immune-checkpoint-inhibitorsnivolumabnon-small-cell-lung-cancerreal-world-evidence
Immunotherapy rechallenge, Immune checkpoint inhibitors, Nivolumab, 1, Real-world evidence, Non-small cell lung cancer, 0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 178175
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.